NEW YORK, NY / ACCESSWIRE / February 10, 2024 / If you have suffered a loss on your BioVie Inc. (NASDAQ:BIVI) and would like to learn more about a potential takeover under the federal securities laws, follow the link below for more information:
or contact Joseph E. Levi, Esq. by email at [email protected] or call (212) 363-7500 to speak with our team of experienced shareholder advocates.
THE TRIAL : A securities class action lawsuit has been filed against BioVie Inc. seeking to recover losses from shareholders who were harmed by alleged securities fraud between August 5, 2021 and November 29, 2023.
CASE DETAILS: The complaint filed alleges that Defendants made false statements and/or concealed the following: (1) BioVie was not conducting appropriate monitoring of its Phase 3 clinical trial; (2) the COVID-19 pandemic has had a significant and negative impact on the Company's ability to adequately conduct appropriate monitoring of the Phase 3 clinical trial; (3) due to the lack of appropriate oversight and reliance on contract research organizations, Defendants' Phase 3 clinical trial data were at increased risk of being unreliable and the majority of patients should be excluded from the trial. 'clinical test ; (4) due to significant exclusions from the trial results, the Phase 3 clinical trial would fail to meet its primary endpoints; and (5) statements regarding BioVie's business, operations, prospects and adherence to current good clinical practices were materially false and/or misleading and/or lacked a reasonable basis at all relevant times.
AND AFTER? If you suffered a loss on BioVie shares during the relevant period – even if you still hold your shares – go to to know your rights to seek compensation. There is no cost or obligation to participate.
WHY LÉVI & KORSINSKI: Over the past 20 years, Levi & Korsinsky LLP has established itself as a nationally recognized securities litigation firm that has obtained hundreds of millions of dollars for injured shareholders and amassed a track record of victories in high-stakes cases. The firm has extensive expertise in representing investors in complex securities litigation and a team of more than 70 employees to serve our clients. For seven consecutive years, Levi & Korsinsky has been ranked in the ISS Securities Class Action Services Top 50 Report as one of the top securities litigation firms in the United States. Lawyer advertising. Previous results do not guarantee similar results.
SOURCE: Levi & Korsinsky, LLP
View original Press release on accesswire.com